AlphaFold predicted structure
SRPK3 · Q9UPE1

Mean pLDDT
78.2/ 100
Confident
567 residues
Confidence breakdown
- Very high(≥ 90)59%
- Confident(70–90)13%
- Low(50–70)3%
- Very low(< 50)25%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
SRSF protein kinase 3
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Congenital myopathy
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesFetal anomalies
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesIntellectual disability
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesLimb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesintellectual developmental disorder, X-linked 114
congenital myopathy
neurodegenerative disease
autosomal recessive limb-girdle muscular dystrophy type 2J
osteoporosis
bone fracture
neurodevelopmental disorder
multiminicore myopathy
exercise intolerance, riboflavin-responsive
amyotrophic lateral sclerosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
SRSF protein kinase 3
Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains. Phosphorylates the SR splicing factor SRSF1 and the lamin-B receptor (LBR) in vitro. Required for normal muscle development (By similarity)
SRPK3 · Q9UPE1

Mean pLDDT
78.2/ 100
Confident
567 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0